Therapeutic strategies to treat CNS pathology in mucopolysaccharidoses

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9206401
APP PUB NO 20130302308A1
SERIAL NO

13996386

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides for nucleotide sequences encoding for a chimeric sulfatase, viral vectors expressing such sequences for gene therapy and pharmaceutical uses of the chimeric expressed protein. The invention is particularly applied in the therapy of mucopolysaccharidosis, preferably type IIIA.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
FONDAZIONE TELETHONITALY ROME ROMA ROME

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ballabio, Andrea Napoli, IT 16 142
Fraldi, Alessandro Napoli, IT 4 10

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 8, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00